Table 2.
Cell line | Exon Targetedb | Multiplicity of infection |
Plating efficiency (%)c | G418R colonies (%)d | G418R colonies analyzede |
G418R colonies targeted (#)f |
Unselected colonies targeted (%)g |
---|---|---|---|---|---|---|---|
OIMSC12 | 4 | 2,000 | 70 | 0.16 | 20 | 65% (13) | 0.10 |
OIMSC12 | 4 | 20,000 | 25 | 0.24 | 15 | 60% (9) | 0.14 |
OIMSC12pa | 4 | 2,000 | 49 | 0.04 | 71 | 92%* | 0.04 |
OIMSC5 | 4 | 2,000 | 69 | 0.04 | 24 | 67% (16) | 0.03 |
OIMSC1pa | 4 | 2,000 | 65 | 0.03 | 55 | 84%* | 0.03 |
OIMSC12 | 2 | 2,000 | 42 | 0.28 | 87 | 82% (71) | 0.23 |
Polyclonal population.
Vectors AAV-COL2e4INloxpA (exon 4) or AAV-COL2e2INloxpA (exon 2).
Colonies obtained without selection per cell plated.
G418-resistant colonies/total number of colonies obtained.
For polyclonal populations, this represents the number of pooled colonies.
(Number of targeted colonies)/(total number of colonies analyzed) × 100.
Polyclonal results based on quantitative Southern blot analysis.
(% G418R colonies targeted) × (% G418R colonies).